Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome

Area of Science:

• Neuroscience
• Genetics
• Biomarker Discovery

Background:

• Rett syndrome (RTT) is a severe X-linked neurodevelopmental disorder caused by MECP2 gene mutations.
• Accurate biomarkers are needed for RTT progression tracking and therapeutic development.
• Circulating microRNAs (miRNAs) are emerging as potential disease indicators.

Purpose of the Study:

• To identify plasma-based miRNA biomarkers for Rett syndrome using a mouse model and human samples.
• To assess the diagnostic accuracy of miRNA biomarkers for RTT detection and progression.
• To explore the potential of circulating miRNAs as non-invasive markers for RTT.

Main Methods:

• Analysis of brain-enriched miRNAs in plasma from Mecp2-mutant mice and human RTT patients.
• Utilized an 'miRNA pair' approach for normalization and classifier development.
• Compared miRNA profiles between RTT models/patients and age-matched controls.

Main Results:

• Specific miRNA pairs and classifiers differentiated wild-type from Mecp2-mutant mice with >90% accuracy.
• miRNA classifiers distinguished RTT patients from controls with 85-100% sensitivity.
• Common miRNA biomarker patterns were observed in both mouse models and human subjects.

Conclusions:

• Circulating miRNAs show significant potential as biomarkers for Rett syndrome progression and treatment response.
• The identified miRNA classifiers offer a minimally invasive approach for RTT diagnosis and monitoring.
• Further large-scale clinical studies are warranted to validate these promising findings.